The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

被引：0
|
作者：
Irene Catucci
Paolo Radice
Roger L. Milne
Fergus J. Couch
Melissa C. Southey
Paolo Peterlongo
机构：
[1] IFOM,Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine
[2] Fondazione Istituto FIRC di Oncologia Molecolare,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health
[3] Fondazione IRCCS Istituto Nazionale dei Tumori,Genetic Epidemiology Laboratory, Department of Pathology
[4] Cancer Epidemiology Centre,undefined
[5] Cancer Council Victoria,undefined
[6] University of Melbourne,undefined
[7] Department of Laboratory Medicine and Pathology,undefined
[8] Mayo Clinic,undefined
[9] The University of Melbourne,undefined
来源：
Breast Cancer Research | / 18卷
关键词：
Breast cancer predisposition; Breast cancer genetic risk factor; p.Leu939Trp; VUS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Germline PALB2 mutation analysis in breast-pancreas cancer families
    Stadler, Zsofia K.
    Salo-Mullen, Erin
    Sabbaghian, Nelly
    Simon, Jennifer A.
    Zhang, Liying
    Olson, Sara H.
    Kurtz, Robert
    Offit, Kenneth
    Foulkes, William D.
    Robson, Mark E.
    Tischkowitz, Marc
    JOURNAL OF MEDICAL GENETICS, 2011, 48 (08) : 523 - 525
  • [32] Analysis of PALB2/FANCN-associated breast cancer families
    Tischkowitz, Marc
    Xia, Bing
    Sabbaghian, Nelly
    Reis-Filho, Jorge S.
    Hamel, Nancy
    Li, Guilan
    van Beers, Erik H.
    Li, Lili
    Khalil, Tayma
    Quenneville, Louise A.
    Omeroglu, Atilla
    Poll, Aletta
    Lepage, Pierre
    Wong, Nora
    Nederlof, Petra M.
    Ashworth, Alan
    Tonin, Patricia N.
    Narod, Steven A.
    Livingston, David M.
    Foulkes, William D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (16) : 6788 - 6793
  • [33] A recurrent mutation in PALB2 in Finnish cancer families
    Erkko, Hannele
    Xia, Bing
    Nikkilae, Jenni
    Schleutker, Johanna
    Syrjaekoski, Kirsi
    Mannermaa, Arto
    Kallioniemi, Anne
    Pylkas, Katri
    Karppinen, Sanna-Maria
    Rapakko, Katrin
    Miron, Alexander
    Sheng, Qing
    Li, Guilan
    Mattila, Henna
    Bell, Daphne W.
    Haber, Daniel A.
    Grip, Mervi
    Reiman, Mervi
    Jukkola-Vuorinen, Arja
    Mustonen, Aki
    Kere, Juha
    Aaltonen, Lauri A.
    Kosma, Veli-Matti
    Kataja, Vesa
    Soini, Ylermi
    Drapkin, Ronny I.
    Livingston, David M.
    Winqvist, Robert
    NATURE, 2007, 446 (7133) : 316 - 319
  • [34] Clinicopathological features of PALB2 and BRCA2 mutation carriers with breast cancer
    Aranda-Gutierrez, Alejandro
    Ferrigno, Ana S.
    Garcia Marrufo, Juan Carlos A.
    Moncada-Madrazo, Mariana
    Gomez-Picos, Analy
    Villarreal-Garza, Cynthia
    Aguilar, Dione
    CANCER RESEARCH, 2021, 81 (04)
  • [35] Comprehensive Sequencing of PALB2 in Patients With Breast Cancer Suggests PALB2 Mutations Explain a Subset of Hereditary Breast Cancer
    Fernandes, Priscilla H.
    Saam, Jennifer
    Peterson, Jenny
    Hughes, Elisha
    Kaldate, Rajesh
    Cummings, Shelly
    Theisen, Aaron
    Chen, Sonia
    Trost, Jeffrey
    Roa, Benjamin B.
    CANCER, 2014, 120 (07) : 963 - 967
  • [36] A recurrent mutation in PALB2 in Finnish cancer families
    Hannele Erkko
    Bing Xia
    Jenni Nikkilä
    Johanna Schleutker
    Kirsi Syrjäkoski
    Arto Mannermaa
    Anne Kallioniemi
    Katri Pylkäs
    Sanna-Maria Karppinen
    Katrin Rapakko
    Alexander Miron
    Qing Sheng
    Guilan Li
    Henna Mattila
    Daphne W. Bell
    Daniel A. Haber
    Mervi Grip
    Mervi Reiman
    Arja Jukkola-Vuorinen
    Aki Mustonen
    Juha Kere
    Lauri A. Aaltonen
    Veli-Matti Kosma
    Vesa Kataja
    Ylermi Soini
    Ronny I. Drapkin
    David M. Livingston
    Robert Winqvist
    Nature, 2007, 446 : 316 - 319
  • [37] A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer
    Velazquez, Carolina
    Esteban-Cardenosa, Eva M.
    Lastra, Enrique
    Abella, Luis E.
    de la Cruz, Virginia
    Lobaton, Carmen D.
    Duran, Mercedes
    Infante, Mar
    BREAST, 2019, 43 : 91 - 96
  • [38] Missense PALB2 germline variant disrupts nuclear localization of PALB2 in a patient with breast cancer
    Ming Ren Toh
    Chen Ee Low
    Siao Ting Chong
    Sock Hoai Chan
    Nur Diana Binte Ishak
    Eliza Courtney
    Arun Mouli Kolinjivadi
    Amélie Rodrigue
    Jean-Yves Masson
    Joanne Ngeow
    Familial Cancer, 2020, 19 : 123 - 131
  • [39] Breast-Cancer Risk in Families With Mutations in PALB2 EDITORIAL COMMENT
    Antoniou, Antonis C.
    Casadei, Silvia
    Heikkinen, Tuomas
    Barrowdale, Daniel
    Pylkas, Katri
    Roberts, Jonathan
    Lee, Andrew
    Subramanian, Deepak
    de Leeneer, Kim
    Fostira, Florentia
    Tomiak, Eva
    Neuhausen, Susan L.
    Teo, Zhi L.
    Khan, Sofia
    Aittomaki, Kristiina
    Moilanen, Jukka S.
    Turnbull, Clare
    Seal, Sheila
    Mannermaa, Arto
    Kallioniemi, Anne
    Lindeman, Geoffrey J.
    Buys, Saundra S.
    Andrulis, Irene L.
    Radice, Paolo
    Tondini, Carlo
    Manoukian, Siranoush
    Toland, Amanda E.
    Miron, Penelope
    Weitzel, Jeffrey N.
    Domchek, Susan M.
    Poppe, Bruce
    Claes, Kathleen B. M.
    Yannoukakos, Drakoulis
    Concannon, Patrick
    Bernstein, Jonine L.
    James, Paul A.
    Easton, Douglas F.
    Goldgar, David E.
    Hopper, John L.
    Rahman, Nazneen
    Peterlongo, Paolo
    Nevanlinna, Heli
    King, Mary-Claire
    Couch, Fergus J.
    Southey, Melissa C.
    Winqvist, Robert
    Foulkes, William D.
    Tischkowitz, Marc
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2014, 69 (11) : 659 - 660
  • [40] PALB2 MUTATIONS IN HIGH-RISK WOMEN WITH OVARIAN OR BREAST CANCER
    Metcalfe, K.
    Lerner-Ellis, J.
    Akbari, M.
    Narod, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 42 - 42
12345